<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-QPA-T-IGAD</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Tuberculosis (&quot;TB&quot;) interventions among refugees in Eastern Africa</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Multicountry Eastern Africa IGAD - Tuberculosis - Intergovernmental Authority on Development - IGAD.  This program has the following goals: To contribute to ending TB  in the IGAD region. The objectives of this program are: To strengthen capacity for TB and MDR-TB diagnosis and TB (TB/HIV) service provision in the refugee camps including cross border health facilities.  To strengthen in-country and cross border collaboration of NTPs/NAPs for improved TB (and TB/HIV) service provision among refugees.  To address policy barriers and related national support to TB and MDR-TB services for refugees in the region</narrative>
  </description>
  <participating-org role="3">
   <narrative xml:lang="EN">Intergovernmental Authority on Development</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Intergovernmental Authority on Development</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="QPA-T-IGAD" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="d141130c-9cfd-4208-a0ac-e784c66b7291" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-07-25" type="1"></activity-date>
  <activity-date iso-date="2018-07-25" type="2"></activity-date>
  <activity-date iso-date="2025-03-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">George SAKVARELIDZE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>george.sakvarelidze@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">George SAKVARELIDZE</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>george.sakvarelidze@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="3"></activity-scope>
  <recipient-region code="QPB" percentage="100" vocabulary="99" vocabulary-uri="https://data-service.theglobalfund.org/v2.1/odata/geographicareas">
   <narrative xml:lang="EN">Multicountry Eastern Africa IGAD</narrative>
  </recipient-region>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="0E92B28E-6628-4A93-91F4-24A0E3F68B43" percentage="0.07" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Communication Material and Publications (CMP)</narrative>
    </description>
   </budget-item>
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="1.99" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="1.74" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="9.13" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="50.35" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="1.73" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="1.5" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="33.48" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-04-01"></period-start>
   <period-end iso-date="2019-06-30"></period-end>
   <value currency="USD" value-date="2019-04-01">368630</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-07-01"></period-start>
   <period-end iso-date="2019-09-30"></period-end>
   <value currency="USD" value-date="2019-04-01">808774</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2019-10-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2019-04-01">775463</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-03-31"></period-end>
   <value currency="USD" value-date="2019-04-01">766531</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-04-01"></period-start>
   <period-end iso-date="2020-06-30"></period-end>
   <value currency="USD" value-date="2019-04-01">585247</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-07-01"></period-start>
   <period-end iso-date="2020-09-30"></period-end>
   <value currency="USD" value-date="2019-04-01">709901</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-10-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2019-04-01">385079</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2019-04-01">713332</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2019-04-01">731262</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2019-04-01">504811</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2019-04-01">2172991</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2019-04-01">407973</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2022-04-01">455974</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2022-04-01">309499</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-04-01">463321</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2022-04-01">492679</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2022-04-01">428911</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2022-04-01">377289</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-12-31"></period-end>
   <value currency="USD" value-date="2022-04-01">400606</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-01-01"></period-start>
   <period-end iso-date="2024-03-31"></period-end>
   <value currency="USD" value-date="2022-04-01">421479</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-04-01"></period-start>
   <period-end iso-date="2024-06-30"></period-end>
   <value currency="USD" value-date="2022-04-01">518689</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-07-01"></period-start>
   <period-end iso-date="2024-09-30"></period-end>
   <value currency="USD" value-date="2022-04-01">309499</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2024-10-01"></period-start>
   <period-end iso-date="2024-12-31"></period-end>
   <value currency="USD" value-date="2022-04-01">400606</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2025-01-01"></period-start>
   <period-end iso-date="2025-03-31"></period-end>
   <value currency="USD" value-date="2022-04-01">421479</value>
  </budget>
  <capital-spend percentage="1.74"></capital-spend>
  <transaction ref="7704482f-4d3a-4eb6-b959-60dea591df14">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-06-20"></transaction-date>
   <value currency="USD" value-date="2019-06-20">3529165</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7a12d360-81a8-4a4a-b57f-b1ecf5d45183">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-09-18"></transaction-date>
   <value currency="USD" value-date="2020-09-18">-213607.41</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="436722a5-72b8-4b31-9bd9-ca353f7f3114">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-09-18"></transaction-date>
   <value currency="USD" value-date="2020-09-18">2464203.55</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="bb54e698-0b5c-4c30-9c2c-f9e1ecea3c0f">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-07-02"></transaction-date>
   <value currency="USD" value-date="2021-07-02">-766531.32</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7969648e-3868-4b02-8cb1-6085c55ce026">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-07-02"></transaction-date>
   <value currency="USD" value-date="2021-07-02">2215127.03</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="363512bf-0669-4ac8-8494-acba48a5e746">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-02-25"></transaction-date>
   <value currency="USD" value-date="2022-02-25">-304388.13</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="8464ae13-f1a8-4bea-b2e9-7b392004decd">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-02-25"></transaction-date>
   <value currency="USD" value-date="2022-02-25">338777</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="64552fa9-cea5-4d23-8f98-1630ce1bd09a">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-05-03"></transaction-date>
   <value currency="USD" value-date="2022-05-03">2150372</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0bed5403-d30b-47a8-813d-da85eefb4a92">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-25"></transaction-date>
   <value currency="USD" value-date="2019-06-25">279137</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6a6f1a5a-f425-41e6-a9c1-54092a9aeae8">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-06"></transaction-date>
   <value currency="USD" value-date="2019-09-06">523000</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e8eb8826-26aa-4291-965a-7452c6419d59">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-06"></transaction-date>
   <value currency="USD" value-date="2019-09-06">690085</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="c4963a62-0bc0-4a23-8677-fc186d5827ea">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-12"></transaction-date>
   <value currency="USD" value-date="2019-11-12">429113</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="eade61f4-5384-4aab-839b-3fcb6d8d123e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-16"></transaction-date>
   <value currency="USD" value-date="2020-04-16">969743</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="cb7574c3-8eb6-4b8d-8b14-084c28d6b684">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-05-13"></transaction-date>
   <value currency="USD" value-date="2020-05-13">307332</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="a36f77d4-9ff0-471f-8098-f487157d2af7">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-16"></transaction-date>
   <value currency="USD" value-date="2020-06-16">117147.59</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0f6f1b03-dfb0-4c48-9c38-e1cb19c91bce">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-23"></transaction-date>
   <value currency="USD" value-date="2020-09-23">1363423.01</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="37b77b0d-edb2-43ac-bb63-b97695b6fa61">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-22"></transaction-date>
   <value currency="USD" value-date="2020-12-22">334249.22</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="85ca0679-1ca3-4a87-ae4e-3632e89b293b">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-08"></transaction-date>
   <value currency="USD" value-date="2021-07-08">852475</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="e3e000f3-8808-4670-b6be-74a3ed402660">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-12"></transaction-date>
   <value currency="USD" value-date="2021-08-12">578867.64</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d6daacf1-22f5-4009-a7ed-3a3baa566442">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-25"></transaction-date>
   <value currency="USD" value-date="2021-11-25">479396.26</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="d4847bc0-21c3-48c8-9e1b-9d854ef12d2e">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-03-03"></transaction-date>
   <value currency="USD" value-date="2022-03-03">338777</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="8545cf9d-1ebb-4fb8-a83d-e0e40d281616">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-05-05"></transaction-date>
   <value currency="USD" value-date="2022-05-05">263499</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QPA-T-IGAD.</narrative>
   </description>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for QPA-T-IGAD</narrative>
   </title>
   <indicator aggregation-status="0" measure="1">
    <title>
     <narrative xml:lang="EN">Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
    </title>
    <baseline value="101" year="2017">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 101</narrative>
     </comment>
    </baseline>
    <baseline value="1276" year="2017">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1276</narrative>
     </comment>
    </baseline>
    <baseline value="1291" year="2017">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1291</narrative>
     </comment>
    </baseline>
    <baseline value="1580" year="2020">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1580</narrative>
     </comment>
    </baseline>
    <baseline value="173" year="2017">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 173</narrative>
     </comment>
    </baseline>
    <baseline value="1929" year="2020">
     <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1929</narrative>
     </comment>
    </baseline>
    <baseline value="1933" year="2017">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 1933</narrative>
     </comment>
    </baseline>
    <baseline value="2207" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 2207</narrative>
     </comment>
    </baseline>
    <baseline value="2216" year="2020">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2216</narrative>
     </comment>
    </baseline>
    <baseline value="2814" year="2020">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2814</narrative>
     </comment>
    </baseline>
    <baseline value="3331" year="2020">
     <dimension name="HIV test status" value="Negative"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3331</narrative>
     </comment>
    </baseline>
    <baseline value="375" year="2020">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 375</narrative>
     </comment>
    </baseline>
    <baseline value="3796" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 3796</narrative>
     </comment>
    </baseline>
    <baseline value="492" year="2017">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 492</narrative>
     </comment>
    </baseline>
    <baseline value="90" year="2020">
     <dimension name="HIV test status" value="Not documented"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 90</narrative>
     </comment>
    </baseline>
    <baseline value="911" year="2017">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 911</narrative>
     </comment>
    </baseline>
    <baseline value="982" year="2020">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 982</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="3000">
      <comment>
       <narrative xml:lang="EN">Numerator: 3000</narrative>
      </comment>
     </target>
     <actual value="115">
      <dimension name="HIV test status" value="Not documented"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 115 Denominator: 3509 Percentage: 3.30</narrative>
      </comment>
     </actual>
     <actual value="1682">
      <dimension name="Gender" value="Female"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 1682 Denominator: 3509 Percentage: 47.90</narrative>
      </comment>
     </actual>
     <actual value="1711">
      <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 1711 Denominator: 3509 Percentage: 48.80</narrative>
      </comment>
     </actual>
     <actual value="1827">
      <dimension name="Gender" value="Male"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 1827 Denominator: 3509 Percentage: 52.10</narrative>
      </comment>
     </actual>
     <actual value="2652">
      <dimension name="Age" value="15+"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 2652 Denominator: 3509 Percentage: 75.60</narrative>
      </comment>
     </actual>
     <actual value="2945">
      <dimension name="HIV test status" value="Negative"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 2945 Denominator: 3394 Percentage: 86.80</narrative>
      </comment>
     </actual>
     <actual value="3509">
      <comment>
       <narrative xml:lang="EN">Numerator: 3509</narrative>
      </comment>
     </actual>
     <actual value="449">
      <dimension name="HIV test status" value="Positive"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 449 Denominator: 3394 Percentage: 13.20</narrative>
      </comment>
     </actual>
     <actual value="857">
      <dimension name="Age" value="&lt;15"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 857 Denominator: 3509 Percentage: 24.40</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="3900">
      <comment>
       <narrative xml:lang="EN">Numerator: 3900</narrative>
      </comment>
     </target>
     <actual value="1580">
      <dimension name="Gender" value="Female"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 1580</narrative>
      </comment>
     </actual>
     <actual value="1929">
      <dimension name="TB case definition" value="Bacteriologically confirmed"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 1929</narrative>
      </comment>
     </actual>
     <actual value="2216">
      <dimension name="Gender" value="Male"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 2216</narrative>
      </comment>
     </actual>
     <actual value="2814">
      <dimension name="Age" value="15+"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 2814</narrative>
      </comment>
     </actual>
     <actual value="3331">
      <dimension name="HIV test status" value="Negative"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 3331</narrative>
      </comment>
     </actual>
     <actual value="375">
      <dimension name="HIV test status" value="Positive"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 375</narrative>
      </comment>
     </actual>
     <actual value="3796">
      <comment>
       <narrative xml:lang="EN">Numerator: 3796</narrative>
      </comment>
     </actual>
     <actual value="90">
      <dimension name="HIV test status" value="Not documented"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 90</narrative>
      </comment>
     </actual>
     <actual value="982">
      <dimension name="Age" value="&lt;15"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 982</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="4500">
      <comment>
       <narrative xml:lang="EN">Numerator: 4500</narrative>
      </comment>
     </target>
     <actual value="4329">
      <comment>
       <narrative xml:lang="EN">Numerator: 4329</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target value="1250">
      <comment>
       <narrative xml:lang="EN">Numerator: 1250</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2023-03-31"></period-end>
     <target value="4000">
      <comment>
       <narrative xml:lang="EN">Numerator: 4000</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target value="4000">
      <comment>
       <narrative xml:lang="EN">Numerator: 4000</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-04-01"></period-start>
     <period-end iso-date="2025-03-31"></period-end>
     <target value="4000">
      <comment>
       <narrative xml:lang="EN">Numerator: 4000</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="1">
    <title>
     <narrative xml:lang="EN">Number of notified TB cases (all forms) contributed by non-national TB program providers &#x2013; community referrals</narrative>
    </title>
    <baseline value="1306" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 1306</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="780">
      <comment>
       <narrative xml:lang="EN">Numerator: 780</narrative>
      </comment>
     </target>
     <actual value="1306">
      <comment>
       <narrative xml:lang="EN">Numerator: 1306</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="900">
      <comment>
       <narrative xml:lang="EN">Numerator: 900</narrative>
      </comment>
     </target>
     <actual value="1624">
      <comment>
       <narrative xml:lang="EN">Numerator: 1624</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="450">
      <comment>
       <narrative xml:lang="EN">Numerator: 450</narrative>
      </comment>
     </target>
     <actual value="720">
      <comment>
       <narrative xml:lang="EN">Numerator: 720</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target value="313">
      <comment>
       <narrative xml:lang="EN">Numerator: 313</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2023-03-31"></period-end>
     <target value="1400">
      <comment>
       <narrative xml:lang="EN">Numerator: 1400</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target value="1440">
      <comment>
       <narrative xml:lang="EN">Numerator: 1440</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-04-01"></period-start>
     <period-end iso-date="2025-03-31"></period-end>
     <target value="1500">
      <comment>
       <narrative xml:lang="EN">Numerator: 1500</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
    </title>
    <baseline value="100.00" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 173 Denominator: 173 Percentage: 100.00</narrative>
     </comment>
    </baseline>
    <baseline value="98.93" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 371 Denominator: 375 Percentage: 98.93</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 369 Denominator: 369 Percentage: 100.00</narrative>
      </comment>
     </target>
     <actual value="99.40">
      <comment>
       <narrative xml:lang="EN">Numerator: 334 Denominator: 336 Percentage: 99.40</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 313 Denominator: 313 Percentage: 100.00</narrative>
      </comment>
     </target>
     <actual value="98.90">
      <comment>
       <narrative xml:lang="EN">Numerator: 371 Denominator: 375 Percentage: 98.90</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 236 Denominator: 236 Percentage: 100.00</narrative>
      </comment>
     </target>
     <actual value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 449 Denominator: 449 Percentage: 100.00</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 103 Denominator: 103 Percentage: 100.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2023-03-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 392 Denominator: 392 Percentage: 100.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 396 Denominator: 396 Percentage: 100.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-04-01"></period-start>
     <period-end iso-date="2025-03-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 400 Denominator: 400 Percentage: 100.00</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative>
    </title>
    <baseline value="46.23" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 1755 Denominator: 3796 Percentage: 46.23</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="43.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 1683 Denominator: 3900 Percentage: 43.20</narrative>
      </comment>
     </target>
     <actual value="46.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 1755 Denominator: 3796 Percentage: 46.20</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="40.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 1200 Denominator: 3000 Percentage: 40.00</narrative>
      </comment>
     </target>
     <actual value="51.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 1815 Denominator: 3509 Percentage: 51.70</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="68.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 3059 Denominator: 4500 Percentage: 68.00</narrative>
      </comment>
     </target>
     <actual value="61.20">
      <comment>
       <narrative xml:lang="EN">Numerator: 2651 Denominator: 4329 Percentage: 61.20</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target value="71.80">
      <comment>
       <narrative xml:lang="EN">Numerator: 897 Denominator: 1250 Percentage: 71.80</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2023-03-31"></period-end>
     <target value="71.80">
      <comment>
       <narrative xml:lang="EN">Numerator: 2872 Denominator: 4000 Percentage: 71.80</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target value="72.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 2880 Denominator: 4000 Percentage: 72.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-04-01"></period-start>
     <period-end iso-date="2025-03-31"></period-end>
     <target value="75.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 3000 Denominator: 4000 Percentage: 75.00</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="1">
    <title>
     <narrative xml:lang="EN">Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
    </title>
    <baseline value="0" year="2017">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Percentage: 0.00</narrative>
     </comment>
    </baseline>
    <baseline value="2" year="2020">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 2</narrative>
     </comment>
    </baseline>
    <baseline value="20" year="2020">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 20</narrative>
     </comment>
    </baseline>
    <baseline value="20" year="2020">
     <dimension name="TB regimen" value="Short regimens"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 20</narrative>
     </comment>
    </baseline>
    <baseline value="25" year="2020">
     <dimension name="Age" value="15+"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 25</narrative>
     </comment>
    </baseline>
    <baseline value="27" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 27</narrative>
     </comment>
    </baseline>
    <baseline value="3" year="2017">
     <dimension name="Gender" value="Male"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 3 Percentage: 0.25</narrative>
     </comment>
    </baseline>
    <baseline value="34" year="2017">
     <dimension name="Age" value="&lt;15"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 34 Percentage: 1.00</narrative>
     </comment>
    </baseline>
    <baseline value="34" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 34</narrative>
     </comment>
    </baseline>
    <baseline value="7" year="2020">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 7</narrative>
     </comment>
    </baseline>
    <baseline value="7" year="2020">
     <dimension name="TB regimen" value="New TB drugs"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 7</narrative>
     </comment>
    </baseline>
    <baseline value="9" year="2017">
     <dimension name="Gender" value="Female"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 9 Percentage: 0.75</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="45">
      <comment>
       <narrative xml:lang="EN">Numerator: 45</narrative>
      </comment>
     </target>
     <actual value="10">
      <dimension name="Gender" value="Female"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 10 Denominator: 28 Percentage: 35.70</narrative>
      </comment>
     </actual>
     <actual value="18">
      <dimension name="Gender" value="Male"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 18 Denominator: 28 Percentage: 64.30</narrative>
      </comment>
     </actual>
     <actual value="2">
      <dimension name="Age" value="&lt;15"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 2 Denominator: 28 Percentage: 7.10</narrative>
      </comment>
     </actual>
     <actual value="2">
      <dimension name="TB regimen" value="New TB drugs"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 2 Denominator: 28 Percentage: 7.10</narrative>
      </comment>
     </actual>
     <actual value="26">
      <dimension name="Age" value="15+"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 26 Denominator: 28 Percentage: 92.90</narrative>
      </comment>
     </actual>
     <actual value="26">
      <dimension name="TB regimen" value="Short regimens"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 26 Denominator: 28 Percentage: 92.90</narrative>
      </comment>
     </actual>
     <actual value="28">
      <comment>
       <narrative xml:lang="EN">Numerator: 28</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="60">
      <comment>
       <narrative xml:lang="EN">Numerator: 60</narrative>
      </comment>
     </target>
     <actual value="2">
      <dimension name="Age" value="&lt;15"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 2</narrative>
      </comment>
     </actual>
     <actual value="20">
      <dimension name="Gender" value="Male"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 20</narrative>
      </comment>
     </actual>
     <actual value="20">
      <dimension name="TB regimen" value="Short regimens"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 20</narrative>
      </comment>
     </actual>
     <actual value="25">
      <dimension name="Age" value="15+"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 25</narrative>
      </comment>
     </actual>
     <actual value="27">
      <comment>
       <narrative xml:lang="EN">Numerator: 27</narrative>
      </comment>
     </actual>
     <actual value="7">
      <dimension name="Gender" value="Female"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 7</narrative>
      </comment>
     </actual>
     <actual value="7">
      <dimension name="TB regimen" value="New TB drugs"></dimension>
      <comment>
       <narrative xml:lang="EN">Numerator: 7</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="60">
      <comment>
       <narrative xml:lang="EN">Numerator: 60</narrative>
      </comment>
     </target>
     <actual value="31">
      <comment>
       <narrative xml:lang="EN">Numerator: 31</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target value="15">
      <comment>
       <narrative xml:lang="EN">Numerator: 15</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2023-03-31"></period-end>
     <target value="40">
      <comment>
       <narrative xml:lang="EN">Numerator: 40</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target value="40">
      <comment>
       <narrative xml:lang="EN">Numerator: 40</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-04-01"></period-start>
     <period-end iso-date="2025-03-31"></period-end>
     <target value="30">
      <comment>
       <narrative xml:lang="EN">Numerator: 30</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">Percentage of registered new and relapse TB patients with documented HIV status</narrative>
    </title>
    <baseline value="95.42" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 2106 Denominator: 2207 Percentage: 95.42</narrative>
     </comment>
    </baseline>
    <baseline value="97.63" year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 3706 Denominator: 3796 Percentage: 97.63</narrative>
     </comment>
    </baseline>
    <baseline value="10.12" year="2020">
     <dimension name="HIV test status" value="Positive"></dimension>
     <comment>
      <narrative xml:lang="EN">Numerator: 375 Denominator: 3706 Percentage: 10.12</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="96.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 2880 Denominator: 3000 Percentage: 96.00</narrative>
      </comment>
     </target>
     <actual value="96.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 3394 Denominator: 3509 Percentage: 96.70</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="98.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 3822 Denominator: 3900 Percentage: 98.00</narrative>
      </comment>
     </target>
     <actual value="97.60">
      <comment>
       <narrative xml:lang="EN">Numerator: 3706 Denominator: 3796 Percentage: 97.60</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 4500 Denominator: 4500 Percentage: 100.00</narrative>
      </comment>
     </target>
     <actual value="95.40">
      <comment>
       <narrative xml:lang="EN">Numerator: 4128 Denominator: 4329 Percentage: 95.40</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 1250 Denominator: 1250 Percentage: 100.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-04-01"></period-start>
     <period-end iso-date="2023-03-31"></period-end>
     <target value="98.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 3920 Denominator: 4000 Percentage: 98.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-04-01"></period-start>
     <period-end iso-date="2024-03-31"></period-end>
     <target value="99.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 3960 Denominator: 4000 Percentage: 99.00</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2024-04-01"></period-start>
     <period-end iso-date="2025-03-31"></period-end>
     <target value="100.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 4000 Denominator: 4000 Percentage: 100.00</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="2">
    <title>
     <narrative xml:lang="EN">Percentage of reporting units reporting no stock-outs of anti-TB drugs on the last day of the quarter</narrative>
    </title>
    <baseline value="93.55" year="2017">
     <comment>
      <narrative xml:lang="EN">Numerator: 58 Denominator: 62 Percentage: 93.55</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2019-04-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target value="97.10">
      <comment>
       <narrative xml:lang="EN">Numerator: 67 Denominator: 69 Percentage: 97.10</narrative>
      </comment>
     </target>
     <actual value="96.80">
      <comment>
       <narrative xml:lang="EN">Numerator: 91 Denominator: 94 Percentage: 96.80</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2021-12-31"></period-end>
     <target value="98.60">
      <comment>
       <narrative xml:lang="EN">Numerator: 68 Denominator: 69 Percentage: 98.60</narrative>
      </comment>
     </target>
     <actual value="90.70">
      <comment>
       <narrative xml:lang="EN">Numerator: 97 Denominator: 107 Percentage: 90.70</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-12-31"></period-end>
     <target value="97.10">
      <comment>
       <narrative xml:lang="EN">Numerator: 67 Denominator: 69 Percentage: 97.10</narrative>
      </comment>
     </target>
     <actual value="97.00">
      <comment>
       <narrative xml:lang="EN">Numerator: 98 Denominator: 101 Percentage: 97.00</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-03-31"></period-end>
     <target value="98.60">
      <comment>
       <narrative xml:lang="EN">Numerator: 68 Denominator: 69 Percentage: 98.60</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
